Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -58.56% | 89.54% | 92.93% | -114.33% | 98.66% |
| Total Depreciation and Amortization | 4.77% | 8.72% | 4.82% | 43.12% | 9.60% |
| Total Amortization of Deferred Charges | -24.45% | -77.39% | 5,349.25% | -38.04% | -- |
| Total Other Non-Cash Items | 1,401.29% | 477.84% | -326.45% | 542.50% | -99.80% |
| Change in Net Operating Assets | -152.00% | 1,408.83% | -37.91% | -163.64% | -91.95% |
| Cash from Operations | 244.94% | 107,704.88% | 190.01% | -139.42% | 126.96% |
| Capital Expenditure | 78.54% | 81.82% | 83.25% | -89.52% | 51.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.62% | 58.65% | 86.46% | -89.02% | 38.56% |
| Total Debt Issued | 141.81% | -81.13% | -61.65% | 143.31% | -75.63% |
| Total Debt Repaid | 18.54% | 71.26% | -89.09% | -102.23% | -290.77% |
| Issuance of Common Stock | -- | -51.59% | 32,766.07% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -12.84% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 68.69% | -- | -- |
| Other Financing Activities | -9.00% | 30.70% | -- | 54.88% | 89.37% |
| Cash from Financing | 90.16% | -139.96% | 93.07% | 73.47% | -293.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.93% | 13,240.63% | 664.21% | -103.96% | 46.01% |
